1. Home
  2. CDLX vs ARAY Comparison

CDLX vs ARAY Comparison

Compare CDLX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$0.88

Market Cap

51.3M

Sector

Technology

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.39

Market Cap

42.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLX
ARAY
Founded
2008
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.3M
42.3M
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
CDLX
ARAY
Price
$0.88
$0.39
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$2.25
$3.50
AVG Volume (30 Days)
1.7M
1.7M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
50.13
87.50
EPS
N/A
N/A
Revenue
$233,273,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.82
$4.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.33
52 Week High
$3.28
$2.10

Technical Indicators

Market Signals
Indicator
CDLX
ARAY
Relative Strength Index (RSI) 46.34 44.16
Support Level $0.88 $0.33
Resistance Level $1.11 $0.63
Average True Range (ATR) 0.13 0.04
MACD 0.00 0.01
Stochastic Oscillator 4.11 57.25

Price Performance

Historical Comparison
CDLX
ARAY

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: